NCT04027556View on ClinicalTrials.gov

Low-contrast Dose Liver CT Using Lean Body Weight Low Monoenergetic Images and Deep Learning-based Reconstruction

NACompletedINTERVENTIONAL
Enrollment

90

Participants

Timeline

Start Date

June 27, 2019

Primary Completion Date

August 26, 2020

Study Completion Date

February 10, 2022

Conditions
Carcinoma, HepatocellularBody Weight
Interventions
OTHER

low dose CT contrast media - lean body weight

CT contrast media (iobitridol 350mgI/kg) is administrated at a dose of 450mgI/kg based on lean body weight.

OTHER

Standard dose CT contrast media

CT contrast media (iobitridol 350mgI/kg) is administrated at a dose of 560mgI/kg based on total body weight.

Trial Locations (1)

Unknown

Seoul National University Hospital, Seoul

All Listed Sponsors
collaborator

Siemens Corporation, Corporate Technology

INDUSTRY

lead

Seoul National University Hospital

OTHER

NCT04027556 - Low-contrast Dose Liver CT Using Lean Body Weight Low Monoenergetic Images and Deep Learning-based Reconstruction | Biotech Hunter | Biotech Hunter